As of 2025-12-28, the Relative Valuation of ACADIA Pharmaceuticals Inc (ACAD) is 28.90 USD. This relative valuation is based on P/E multiples. With the latest stock price at 27.62 USD, the upside of ACADIA Pharmaceuticals Inc based on Relative Valuation is 4.6%.
The range of the Relative Valuation is 27.43 - 32.86 USD.
| Range | Selected | |
| Trailing P/E multiples | 18.0x - 19.6x | 18.2x |
| Forward P/E multiples | 18.7x - 22.4x | 20.3x |
| Fair Price | 27.43 - 32.86 | 28.90 |
| Upside | -0.7% - 19.0% | 4.6% |
| Date | P/E |
| 2025-12-26 | 17.89 |
| 2025-12-24 | 18.05 |
| 2025-12-23 | 18.03 |
| 2025-12-22 | 18.18 |
| 2025-12-19 | 17.59 |
| 2025-12-18 | 17.23 |
| 2025-12-17 | 17.44 |
| 2025-12-16 | 17.36 |
| 2025-12-15 | 17.66 |
| 2025-12-12 | 17.59 |
| 2025-12-11 | 17.28 |
| 2025-12-10 | 17.37 |
| 2025-12-09 | 17.42 |
| 2025-12-08 | 17.33 |
| 2025-12-05 | 17.77 |
| 2025-12-04 | 17.20 |
| 2025-12-03 | 16.76 |
| 2025-12-02 | 16.47 |
| 2025-12-01 | 16.10 |
| 2025-11-28 | 16.22 |
| 2025-11-26 | 16.07 |
| 2025-11-25 | 15.80 |
| 2025-11-24 | 15.48 |
| 2025-11-21 | 15.26 |
| 2025-11-20 | 14.83 |
| 2025-11-19 | 14.96 |
| 2025-11-18 | 15.42 |
| 2025-11-17 | 15.55 |
| 2025-11-14 | 15.56 |
| 2025-11-13 | 15.31 |
| 2025-11-12 | 15.63 |
| 2025-11-11 | 15.37 |
| 2025-11-10 | 14.38 |
| 2025-11-07 | 14.62 |
| 2025-11-06 | 14.02 |
| 2025-11-05 | 14.46 |
| 2025-11-04 | 14.15 |
| 2025-11-03 | 14.49 |
| 2025-10-31 | 14.70 |
| 2025-10-30 | 14.73 |
| 2025-10-29 | 14.59 |
| 2025-10-28 | 14.65 |
| 2025-10-27 | 14.89 |
| 2025-10-24 | 14.26 |
| 2025-10-23 | 14.08 |
| 2025-10-22 | 13.86 |
| 2025-10-21 | 13.78 |
| 2025-10-20 | 13.56 |
| 2025-10-17 | 13.53 |
| 2025-10-16 | 13.36 |